Calibrium

company

About

Calibrium is an emerging privately held biopharmaceutical company.

  • 251 - 500

Details

Industries
Biotechnology,Health Care
Founded date
Jan 1, 2012
Number Of Employee
251 - 500
Operating Status
Active

Calibrium is an emerging privately-held biopharmaceutical company focused on developing a portfolio of novel drug candidates for the treatment of diabetes and related metabolic diseases. Calibrium was co-founded by Fritz French, Calibrium’s Chief Executive Officer, and Richard DiMarchi, PhD, Calibirum’s Chief Scientific Officer.